[AF] fenofibrato

[Pedro del Río Pérez]

Reciente de hace un momento:

"FDA Issues 'Safety Communication' on Fenofibrate
The US FDA has issued a safety communication and updated the prescribing
information for the cholesterol-lowering agent fenofibric acid (Trilipix, 
Abbott),
stating that the drug may not lower the risk of major cardiovascular events 
[1].
This is based on data from the ACCORD Lipid trial, in which the combination
of fenofibrate plus simvastatin was compared with simvastatin alone in
patients with type 2 diabetes mellitus....."
<http://www.medscape.com/viewarticle/753195?sssdmh=dm1.732627&src=nl_newsalert>

Requiere suscripción, pero es gratis.

Saludos
.............................................
Pedro del Río Pérez
León
pedrodelrio en uninet.edu
.............................................